| KCT0008022 |
The effect of preconception care program for women with inflammatory bowel disease: a mixed method study |
Not Available |
Not Recruiting |
University of Ulsan |
;Diseases of the digestive system |
Behavioral, Others(Education) : The experimental … |
Details |
| NL-OMON49003 |
A randomised controlled trial comparing FMT (fecal microbiota transplantation) after budesonide or placebo in patients with active ulcerative colitis: ;Acronym: the FECBUD trial __ - FMT for ulcerative colitis after initiation of budesonide |
Not Available |
Not Recruiting |
Leids Universitair Medisch Centrum |
inflammatory bowel disease ulcerative colitis;10… |
Intervention Patients with active ulcerative coli… |
Details |
| NL-OMON44482 |
A randomised controlled trial comparing FECal Microbiota Transplantation after BUDesonide or placebo induction in patients with ulcerative colitis; the FECBUD trial__ - FMT for ulcerative colitis after initiation of budesonide |
Not Available |
None |
Haaglanden Medisch Centrum |
inflammatory bowel disease ulcerative colitis;10… |
Intervention Patients with active ulcerative coli… |
Details |
| CTRI/2017/10/010160 |
Evaluation of a Peri-Operative Low Dose Steroid Regimen for Steroid Treated Inflammatory Bowel Disease patients A Prospective Randomised Study |
PHASE2|PHASE3 |
Recruiting |
AIIMS |
Health Condition 1: null- patient having infalmma… |
Intervention1: Low dose Steroid (LDS) Regimen: Pa… |
Details |
| NCT03863886 |
Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis |
None |
UNKNOWN |
Carilion Clinic |
Crohn Disease|Ulcerative Colitis |
PROCEDURE: Endoscopic ultrasound catheter (UM-2R/… |
Details |
| NCT02293811 |
Decoding of the Expression of Tumor Suppressor P2RX7 in Inflammatory and Malignant Colonic Mucosa |
None |
TERMINATED |
Centre Hospitalier Universitaire de Nice |
Crohn Disease-Associated Colorectal Adenocarcinoma |
OTHER: Analysis |
Details |
| NCT04985968 |
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis |
PHASE3 |
TERMINATED |
InDex Pharmaceuticals |
Ulcerative Colitis |
DRUG: Cobitolimod 250 mg|DRUG: Cobitolimod 500 mg… |
Details |
| NCT06681181 |
A First-time in Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK4528287 in Healthy Participants |
PHASE1 |
RECRUITING |
GlaxoSmithKline |
Colitis, Ulcerative |
DRUG: GSK4528287|DRUG: Placebo |
Details |
| NCT05992142 |
ChAracterizing the Remission Status in Patients With Ulcerative Colitis Treated by 5-ASA |
PHASE4 |
COMPLETED |
Belgian Inflammatory Bowel Disease Research and Development (BIRD) VZW |
Ulcerative Colitis |
DRUG: 5-ASA |
Details |
| NCT00787202 |
A Study To Investigate The Safety And Efficacy Of CP- 690,550 In Patients With Moderate And Severe Ulcerative Colitis. |
PHASE2 |
COMPLETED |
Pfizer |
Ulcerative Colitis |
DRUG: CP- 690 550|DRUG: CP- 690 550|DRUG: CP- 690… |
Details |
| NCT06321887 |
EffiCacy and sAfEty of Low doSe orAl iRon for Anaemia in IBD |
PHASE3 |
RECRUITING |
Liverpool University Hospitals NHS Foundation Trust |
Inflammatory Bowel Disease|Iron Deficiency Anemia |
DRUG: Ferrous fumarate syrup 2.5ml/70mg (22.5mg e… |
Details |
| NCT00207688 |
A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients |
None |
COMPLETED |
Janssen Research & Development, LLC |
Ulcerative Colitis |
DRUG: Infliximab 5 mg/kg|DRUG: Infliximab 10 mg/k… |
Details |
| NCT04677179 |
A Study of LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC) |
PHASE2 |
TERMINATED |
Nektar Therapeutics |
Colitis, Ulcerative |
DRUG: LY3471851|DRUG: Placebo |
Details |
| NCT02958865 |
Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis |
PHASE2 |
COMPLETED |
Pfizer |
Ulcerative Colitis |
DRUG: PF-06651600 or Placebo|DRUG: PF-06700841 or… |
Details |
| NCT03943550 |
Double-Blinded, Placebo-Controlled Phase 1b Study for Safety, PK, Efficacy, PD of RO7049665 in Participants With Ulcerative Colitis (UC) |
PHASE1 |
TERMINATED |
Hoffmann-La Roche |
Ulcerative Colitis |
DRUG: RO7049665|DRUG: Placebo |
Details |
| NCT02840721 |
Safety, Efficacy, and Tolerability Study of PF-06480605 in Subjects With Moderate to Severe Ulcerative Colitis. |
PHASE2 |
COMPLETED |
Telavant, Inc. |
Colitis, Ulcerative |
DRUG: PF-06480605 |
Details |
| NCT04133194 |
Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis |
PHASE4 |
RECRUITING |
Flemming Bendtsen |
Ulcerative Colitis |
DRUG: Mesalazine|DRUG: Mesalazine |
Details |
| NCT01465763 |
A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis |
PHASE3 |
COMPLETED |
Pfizer |
Ulcerative Colitis |
DRUG: tofacitinib|DRUG: Placebo |
Details |
| NCT06636656 |
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis |
PHASE2 |
RECRUITING |
Boehringer Ingelheim |
Ulcerative Colitis |
DRUG: BI 3032950 intravenous (Part A)|DRUG: BI 30… |
Details |
| NCT04996797 |
A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005) |
PHASE2 |
ACTIVE_NOT_RECRUITING |
Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) |
Ulcerative Colitis |
DRUG: Tulisokibart|DEVICE: Companion Diagnostic (… |
Details |
